| abstract |
Biocompatible iron oxide nanoparticles for use in a method to treat a process related to iron deficiency, the method comprising: Identifying a patient who has a process related to iron deficiency; and Administer an effective amount of biocompatible iron oxide nanoparticles to the patient, the biocompatible iron oxide nanoparticles each containing an iron oxide core that is covered by one or more biocompatible polymers, each of which has a polyethylene glycol group , a silane group, and a linker that links, through a covalent bond, the polyethylene glycol group and the silane group. |